The latest announcement is out from Hansoh Pharmaceutical Group Company Limited ( (HK:3692) ).
Hansoh Pharmaceutical Group Company Limited has announced changes in its corporate secretariat and representation roles, effective January 24, 2025. Ms. Tam Sze Wai Sara has resigned from her roles due to personal work arrangements, and Ms. Wong Yuen Ki has been appointed as the new joint company secretary, authorized representative, and process agent, highlighting the company’s commitment to maintaining strong corporate governance.
More about Hansoh Pharmaceutical Group Company Limited
Hansoh Pharmaceutical Group Company Limited is a pharmaceutical company incorporated in the Cayman Islands, focusing on the development, production, and sale of innovative drugs. The company operates in the healthcare sector and is listed on the Hong Kong Stock Exchange.
YTD Price Performance: 0.0%
Average Trading Volume: 7,064,193
Technical Sentiment Consensus Rating: Hold
Current Market Cap: HK$102.6B
For a thorough assessment of 3692 stock, go to TipRanks’ Stock Analysis page.